Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
19.73
-0.58 (-2.86%)
At close: Oct 23, 2026, 4:00 PM EDT
19.62
-0.11 (-0.54%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Acadia Pharmaceuticals Employees
As of December 31, 2025, Acadia Pharmaceuticals had 798 total employees, including 796 full-time and 2 part-time employees. The number of employees increased by 144 or 22.02% compared to the previous year. That makes Acadia Pharmaceuticals the 16,531st largest employer in the world and 2,339th in the United States.
Employees
798
Change (1Y)
144
Growth (1Y)
22.02%
Revenue / Employee
$1,426,872
Profits / Employee
$476,797
Market Cap
3.40B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Telix Pharmaceuticals | 1,184 |
| AbCellera Biologics | 562 |
| Xenon Pharmaceuticals | 370 |
| Tarsus Pharmaceuticals | 370 |
| Relay Therapeutics | 202 |
| Disc Medicine | 165 |
| Celcuity | 155 |
ACAD News
- 3 days ago - Acadia Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 4, 2026 - Business Wire
- 11 days ago - Acadia Pharmaceuticals Slides: Corporate presentation - Filings
- 11 days ago - Acadia Pharmaceuticals downgraded to Neutral from Buy at UBS - TheFly
- 16 days ago - Acadia Pharmaceuticals price target lowered to $36 from $37 at RBC Capital - TheFly
- 19 days ago - Acadia looks to have settled case with Zydus, says RBC Capital - TheFly
- 26 days ago - Acadia Pharmaceuticals announces USPTO allowance of patent covering Trofinetide - TheFly
- 26 days ago - Acadia Pharmaceuticals Announces Allowance of U.S. Patent Covering Weight-Banded Dosing of Trofinetide, extending U.S. patent protections to March 2041 - Business Wire
- 4 weeks ago - Acadia price target lowered to $33 from $37 at H.C. Wainwright - TheFly